CLASS II ONGOING Device recall · Reported 5 Jun 2024 · FDA Enforcement Report

Oxinium Femoral Head 12/14 Taper recalled by Smith & Nephew

Smith & Nephew is recalling Oxinium Femoral Head 12/14 Taper. The recall was initiated on 24 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033.
Quantity recalled23 packages

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1901-2024
FDA event ID
94555
Recalling firm
Smith & Nephew, Memphis, TN
Classification
Class II
Status
Ongoing
Recall initiated
24 Apr 2024
FDA classified
24 May 2024
Reported
5 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

24 Apr 2024Recall initiated by company
24 May 2024Classified by FDA+30 days
5 Jun 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Packaging contained the incorrect size of femoral head from what was displayed on the label.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4

Where it was distributed

International distribution to the countries of Australia, Germany, Japan, Portugal, and United Kingdom.

Questions about this recall

Why was it recalled?

Packaging contained the incorrect size of femoral head from what was displayed on the label.

Which lots are affected?

REF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033.

Where was it sold?

International distribution to the countries of Australia, Germany, Japan, Portugal, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Smith & Nephew

All 259

Other Hip & Knee Implants recalls

All 3,123